PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES

Author:

Kaprin A. D.1ORCID,Kostin A. A.2ORCID,Epifanova M. V.3ORCID,Chalyy M. E.4,Gameeva E. V.5,Artemenko S. A.6ORCID

Affiliation:

1. National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Medical Institute of Peoples' Friendship University of Russia (RUDN University)

2. National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Peoples' Friendship University of Russia (RUDN University)

3. Medical Institute of Peoples' Friendship University of Russia (RUDN University) Peoples' Friendship University of Russia (RUDN University)

4. Medical Research and Education Center of Lomonosov Moscow State University

5. P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

6. I.M.Sechenov First Moscow State Medical University (Sechenov University)

Abstract

Erectile dysfunction is no longer a psychosocial problem. Nowadays, it is a marker specific for the initial stages of cardiovascular diseases. Рlatelet-rich plasma (PRP) is a new and promising method, which totally deserves to be noted by specialists. To review currently existing pre-clinical and clinical studies concerning application of PRP in erectile dysfunction published in international sources such as PubMed, Cochrane Library, Clinicaltrials.gov. The current data of preclinical and clinical studies determine the absence of PRP side effects and the effectiveness for ED treatment. PRP-therapy is a pathogenetically substantiated method of treating erectile dysfunction. The therapy is designed for repair and regeneration of endothelium, smooth muscle cells, and connective tissue. However, large, placebo-controlled, multicenter studies are needed to creation a systematic review and meta-analysis.

Publisher

QUASAR, LLC

Subject

Microbiology (medical),Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3